Accurate, Focused Research on Law, Technology and Knowledge Discovery Since 2002

Category Archives: Medicine

The Worst Covid Strategy Was Not Picking One

Bloomberg: The lessons of the pandemic are clearer in a global comparison. Three years after the World Health Organization declared Covid-19 to be a pandemic, we finally have reason to celebrate: Global deaths from the virus have dipped below 1,000 people per day for the first time since March 2020. But with almost 7 million… Continue Reading

Yet Another Problem With Recycling: It Spews Microplastics

Wired – “Recycling was already a mess. Now a study finds that one facility may emit 3 million pounds of microplastics a year. The plastics industry has long hyped recycling, even though it is well aware that it’s been a failure. Worldwide, only 9 percent of plastic waste actually gets recycled. In the United States, the rate… Continue Reading

Mifepristone is under scrutiny in the courts, but it has been used safely and effectively around the world for decades

Via LLRX – Mifepristone is under scrutiny in the courts, but it has been used safely and effectively around the world for decades – A flurry of court rulings in April 2023 has left the future of the abortion pill mifepristone in question. For now, a U.S. Supreme Court decision on April 21 allows the drug… Continue Reading

Lessons from the Covid War: An Investigative Report Paperback

“What went right and wrong in our nation’s response to the pandemic? What can we do to avoid the next one? In Lessons from the Covid War: An Investigative Report, the nonpartisan Covid Crisis Group offers crucial recommendations to prepare for the inevitable next public health crisis. The Covid Crisis Group—led by UVA history professor Philip Zelikow, the… Continue Reading

WHO releases the largest global collection of health inequality data

“Today, WHO is launching the Health Inequality Data Repository, the most comprehensive global collection of publicly available disaggregated data and evidence on population health and its determinants. The repository allows for tracking health inequalities across population groups and over time, by breaking down data according to group characteristics, ranging from education level to ethnicity. The… Continue Reading

Long COVID Is Being Erased—Again

The Atlantic: “…Most Americans simply aren’t thinking about COVID with the same acuity they once did; the White House long ago zeroed in on hospitalizations and deaths as the measures to worry most about. And what was once outright denial of long COVID’s existence has morphed into something subtler: a creeping conviction, seeded by academics… Continue Reading

HHS Making Ownership Data for All Medicare-Certified Hospice and Home Health Agencies Publicly Available

CMS – “The Biden-Harris Administration has made promoting competition and protecting consumers a top priority. Today, in support of the President’s Executive Order on promoting competition and the Administration’s commitment to transparency, the U.S. Department of Health and Human Services (HHS) is releasing ownership data for all Medicare-certified hospice and home health agencies. For the… Continue Reading

GPT-4 will hunt for trends in medical records thanks to Microsoft and Epic

ars technica – Generative AI promises to streamline health care, but critics say not so fast. “On Monday [April 17, 2023], Microsoft and Epic Systems announced that they are bringing OpenAI’s GPT-4 AI language model into health care for use in drafting message responses from health care workers to patients and for use in analyzing… Continue Reading

Primer – Artificial Intelligence, Human Rights, Democracy, and the Rule of Law

The Alan Turing Institute and the Council of Europe: Primer – Artificial Intelligence, Human Rights, Democracy, and the Rule of Law: “…It is a remarkable fact that rapid advancements in artificial intelligence (AI) and data-driven technologies over the last two decades have placed contemporary society at a pivot-point in deciding what shape the future of… Continue Reading

U.S. appeals court preserves limited access to abortion pill

Reuters: “The abortion pill mifepristone will remain available in the United States for now but with significant restrictions, including a requirement for in-person doctor visits to obtain the drug, a federal appeals court ruled late on Wednesday. The New Orleans-based 5th U.S. Circuit Court of Appeals put on hold part of last Friday’s order by… Continue Reading